Baars JW - Search Results

1

Mobilisation of blood progenitor cells with ifosfamide and etoposide (VP-16) in combination with recombinant human G-CSF (Filgrastim) in patients with malignant lymphomas or solid tumours.

Baars JW, Holtkamp MJ, Nooyen WJ, Walll EV, Te Velde A, Dalesio O, Slaper-Cortenbach IC, Schoot EV, Richel DJ, Gerritsen WR, Schornagel JH, Rodenhuis S. Baars JW, et al. Anticancer Res. 1996 Sep-Oct;16(5B):3089-95. Anticancer Res. 1996. PMID: 8920773

2

Feasibility and toxicity study of a high-dose chemotherapy regimen for autotransplantation incorporating carboplatin, cyclophosphamide and thiotepa.

Rodenhuis S, Baars JW, Schornagel JH, Vlasveld LT, Mandjes I, Pinedo HM, Richel DJ. Rodenhuis S, et al. Among authors: baars jw. Ann Oncol. 1992 Dec;3(10):855-60. doi: 10.1093/oxfordjournals.annonc.a058111. Ann Oncol. 1992. PMID: 1286049 Free article. Clinical Trial.

3

Phase I study on the sequential administration of recombinant human interferon-gamma and recombinant human interleukin-2 in patients with metastatic solid tumors.

Baars JW, Wagstaff J, Boven E, Vermorken JB, van Groeningen CJ, Scheper RJ, Fonk JC, Nijman HW, Franks CR, Damsma O, et al. Baars JW, et al. J Natl Cancer Inst. 1991 Oct 2;83(19):1408-10. doi: 10.1093/jnci/83.19.1408. J Natl Cancer Inst. 1991. PMID: 1920484 Clinical Trial. No abstract available.

4

High-dose carboplatin, thiotepa and cyclophosphamide (CTC) with peripheral blood stem cell support in the adjuvant therapy of high-risk breast cancer: a practical approach.

van der Wall E, Nooijen WJ, Baars JW, Holtkamp MJ, Schorangel JH, Richel DJ, Rutgers EJ, Slaper-Cortenbach IC, van der Schoot CE, Rodenhuis S. van der Wall E, et al. Among authors: baars jw. Br J Cancer. 1995 Apr;71(4):857-62. doi: 10.1038/bjc.1995.165. Br J Cancer. 1995. PMID: 7536025 Free PMC article. Clinical Trial.

5

Subsets of CD34+ cells and rapid hematopoietic recovery after peripheral-blood stem-cell transplantation.

Dercksen MW, Rodenhuis S, Dirkson MK, Schaasberg WP, Baars JW, van der Wall E, Slaper-Cortenbach IC, Pinedo HM, Von dem Borne AE, van der Schoot CE, et al. Dercksen MW, et al. Among authors: baars jw. J Clin Oncol. 1995 Aug;13(8):1922-32. doi: 10.1200/JCO.1995.13.8.1922. J Clin Oncol. 1995. PMID: 7543561

6

[Favorable effect of hematopoietic stem cells isolated from blood on hematologic recovery following high-dosage chemotherapy].

Richel DJ, Baars JW, Wijngaarden MJ, van der Schoot CE, Vlasveld LT, Rodenhuis S. Richel DJ, et al. Among authors: baars jw. Ned Tijdschr Geneeskd. 1993 Jan 30;137(5):245-50. Ned Tijdschr Geneeskd. 1993. PMID: 7679478 Dutch.

7

Feasibility of multiple courses of high-dose cyclophosphamide, thiotepa, and carboplatin for breast cancer or germ cell cancer.

Rodenhuis S, Westermann A, Holtkamp MJ, Nooijen WJ, Baars JW, van der Wall E, Slaper-Cortenbach IC, Schornagel JH. Rodenhuis S, et al. Among authors: baars jw. J Clin Oncol. 1996 May;14(5):1473-83. doi: 10.1200/JCO.1996.14.5.1473. J Clin Oncol. 1996. PMID: 8622061 Clinical Trial.

8

Efficacy of up-front 5-fluorouracil-epidoxorubicin-cyclophosphamide (FEC) chemotherapy with an increased dose of epidoxorubicin in high-risk breast cancer patients.

van der Wall E, Rutgers EJ, Holtkamp MJ, Baars JW, Schornagel JH, Peterse JL, Beijnen JH, Rodenhuis S. van der Wall E, et al. Among authors: baars jw. Br J Cancer. 1996 May;73(9):1080-5. doi: 10.1038/bjc.1996.208. Br J Cancer. 1996. PMID: 8624267 Free PMC article. Clinical Trial.

9

Hemolytic uremic syndrome after high dose chemotherapy with autologous stem cell support.

van der Lelie H, Baars JW, Rodenhuis S, van Dijk MA, de Glas-Vos CW, Thomas BL, van Oers RH, von dem Borne AE. van der Lelie H, et al. Among authors: baars jw. Cancer. 1995 Dec 1;76(11):2338-42. doi: 10.1002/1097-0142(19951201)76:11<2338::aid-cncr2820761123>3.0.co;2-p. Cancer. 1995. PMID: 8635040 Review.

10

The toxicity of radiotherapy following high-dose chemotherapy with peripheral blood stem cell support in high-risk breast cancer: a preliminary analysis.

van der Wall E, Schaake-Koning CC, van Zandwijk N, Baars JW, Schornagel JH, Richel DJ, Rutgers EJ, Borger JH, Beijnen JH, Rodenhuis S. van der Wall E, et al. Among authors: baars jw. Eur J Cancer. 1996 Aug;32A(9):1490-7. doi: 10.1016/0959-8049(96)00129-3. Eur J Cancer. 1996. PMID: 8911107 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

80 results

Search Page